skip to navigation

Diabetic Retinopathy: A Position Statement by the American Diabetes Association

Authored by American Diabetes Association
Posted on March 16, 2017
Topic: Advocacy/Vision 2020, Diabetic Eye Care
Region: North America
Not yet rated

http://care.diabetesjournals.org/content/40/3/412

Diabetic retinopathy diagnostic assessment and treatment options have improved dramatically since the 2002 American Diabetes Association Position Statement. These improvements include the widespread adoption of optical coherence tomography to assess retinal thickness and intraretinal pathology and wide-field fundus photography to reveal clinically silent microvascular lesions. Treatment of diabetic macular edema is now achieved by intravitreous injection of anti–vascular endothelial growth factor agents, and the same drugs are now used for proliferative diabetic retinopathy. Improvements in medications and devices for the systemic therapy of diabetes have also improved the ability of patients to optimize their metabolic control. This Position Statement incorporates these recent developments for the use of physicians and patients.

Access the paper on ADA's website

Stay connected:         Follow us on Instagram

Web site design and web development by D3 Solutions